Clinical Trial

The Gut Microbiota in Obsessive-Compulsive Disorder

Study Description

The Gut Microbiota in Obsessive-Compulsive Disorder

This study will examine the gut microbiota and serum inflammatory markers in patients with Obsessive-Compulsive Disorder vs. healthy controls. Phase II of the study will examine the gut microbiota and cytokine levels following 12-weeks of treatment with Selective Serotonin Reuptake Inhibitors (SSRIs).

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - SSRIs

12-weeks of standard SSRi treatment for those interested in Phase II of the study.

Additional Information

Official Study Title

A Pilot Study Examining the Gut Microbiota in Patients With Obsessive-Compulsive Disorder vs. Healthy Controls and Following 12-weeks of Open-label Selective Serotonin Reuptake Inhibitors Treatment

Clinical Trial ID

NCT02285699

ParticipAid ID

YerEkd